valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

Owlet, Inc. (OWLT) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$1.20 ComplexityHigh Updated
$0.00 $8.50
bear $0.00 base $3.00 bull $8.50 margin of safety $1.20 market price* $4.11
Business condition attached to the margin of safety A second reported quarter (any quarter, not just the historically strong pre-holiday quarter) of positive owner earnings, on top of the one already seen in Q3 2025, confirming the improvement is structural rather than seasonal.
Owlet makes the Dream Sock and BabySat baby monitors plus the Owlet360 subscription app, sold mainly through major U.S. retailers (Amazon, Walmart, Target, Best Buy) and increasingly direct-to-consumer, with a growing international business in Europe, Canada, Australia and a few other markets. The company went public via SPAC merger in 2021, came close to running out of cash in 2022-2023, and completed a 1-for-15 reverse stock split and a recapitalization (new preferred stock, warrants and a term loan) to survive. That history is relevant background, not a live concern: the FY2025 audited financial statements were not qualified for going-concern doubt, and management points to $35.5 million of cash at year-end plus an asset-based credit line as sufficient for the next twelve months, following a $32 million common stock offering completed in October 2025. The business is still unprofitable on a cash basis, but the trend is real and multi-year: owner earnings per share (operating cash flow minus the working-capital swing, minus stock compensation, minus the small amount of capital spending the business needs to keep running) improved from about -$9.37 in 2022 to -$3.26 in 2023, -$1.65 in 2024 and -$0.49 in 2025, as revenue grew from a 2023 trough of $54 million to $106 million in 2025 and stock-based compensation shrank as a share of sales. A large non-cash loss on the fair-value of warrants ($26.6 million in 2025) explains most of the gap between the reported net loss and the much smaller cash loss; that item is a legacy financing artifact, not an operating cost, and has been treated as such. The improvement has not been a straight line, however. The one profitable quarter on record, the third quarter of 2025, was immediately followed by a $9.1 million net loss in the fourth quarter, and the first half of 2026 was still cash-flow negative. That pattern argues against assuming the turnaround is complete, and none of the three cases below assume it is. Bear case: growth slows sharply and the operating-cost discipline of the last two years does not hold, so cash losses persist near today's level for years. The company has raised dilutive capital four times since 2024 (preferred stock, two common offerings, a term loan), and a repeat of that pattern would keep shrinking the value of each existing share even though the company itself survives. Net cash and debt are close to a wash today (roughly $13.9 million of borrowings and a $20.7 million preferred liquidation preference against $35.5 million of cash), so there is little balance-sheet cushion beyond what operations can generate. Value in this case is essentially zero per share. Base case: revenue growth decelerates from the 35% pace of 2025 to the high single digits within a few years as the U.S. retail base matures, while the cost discipline already shown over the past two years (low stock compensation growth, minimal capital spending) continues. On that path, cash losses narrow further and the business crosses into modest sustained profitability within the next several years, without assuming any new markets or products beyond what is already sold today. We estimate this is worth roughly $3 per share today. Bull case: two things already in place, but not yet fully monetized, work as intended: the FDA clearance already granted for BabySat opens a healthcare/insurance reimbursement channel, and the seven international regulatory clearances already obtained let Owlet sell through existing retail relationships abroad without needing new approvals. If both convert into revenue at a healthy pace, profitability arrives sooner and compounds for longer. We estimate this case is worth roughly $8.50 per share. We are not assigning value to anything that has not already happened - not a hoped-for market recovery, not unannounced products, not management's own targets. Given how much of the base and bull cases still depend on a turnaround that is only partly proven so far, the margin-of-safety price is set at a large discount to our estimate of fair value, and it takes effect only after one more quarter of confirmed cash profitability outside the seasonally strongest quarter.
Fiscal yearOwner's earningsMethodology
2025 -$0.49 ▼
OE = CFO - WC - SBC - maintenance capex. CFO=$(10,792)K. WC effect (from cash-flow statement 'Changes in assets and liabilities'): AR $(10,971)K + prepaid $(1,048)K + inventory $(4,927)K + AP/accrued +$5,426K + lease $(100)K + other liab $(769)K + deferred rev +$912K = $(11,477)K. Reconciliation check: net loss $(39,678)K + all non-cash addbacks (D&A, SBC, warrant fair-value loss $26,571K, impairment, debt-cost amortization, other) sum to within ~2% of CFO-WC, confirming no missed/mis-signed item. SBC=$9,348K. Capex=$273K; revenue grew $27,652K YoY; capex_ratio(FY23-25 avg)=~0.11% so growth capex=~$31K, maintenance capex=$242K. OE = -10,792-(-11,477)-9,348-242 = $(8,905)K. Diluted shares=18,093,925. OE/sh=$(0.49). Note: the large non-cash 'common stock warrant liability adjustment' ($26,571K loss) that drove the big gap between net loss and CFO is a fair-value remeasurement of legacy SPAC/financing warrants, correctly added back per the CFO-based method; it is not an operating cost. Source: FY2025 10-K filed 2026-03-09, accession 0001816708-26-000018.
2024 -$1.65 ▼
OE = CFO - WC - SBC - maintenance capex. CFO=$(11,209)K. WC effect: AR +$2,030K + prepaid $(30)K + inventory $(4,139)K + AP/accrued +$1,322K + lease $(1,178)K + deferred rev +$240K = $(1,755)K. SBC=$8,633K. Capex=$35K; revenue grew $24,046K YoY; capex_ratio (FY23-25 avg, capex/revenue)=~0.11% so growth capex=~$27K (clamped), maintenance capex=~$9K. OE = -11,209-(-1,755)-8,633-9 = $(18,096)K. Diluted shares=10,951,270. OE/sh=$(1.65). Source: FY2025 10-K comparative column, accession 0001816708-26-000018.
2023 -$3.26 ▼
OE = CFO - WC - SBC - maintenance capex. CFO=$(23,527)K. WC effect: AR +$965K + inventory +$12,118K + AP/accrued $(19,503)K + deferred rev $(84)K = $(6,504)K. SBC=$9,933K. Capex=$16K; revenue declined YoY (54,010 vs 69,202) so growth capex=$0, maintenance capex=capex=$16K. OE = -23,527-(-6,504)-9,933-16 = $(26,972)K. Diluted shares=8,276,481. OE/sh=$(3.26). Source: FY2023 10-K filed 2025-03-11, accession 0001628280-25-012035.
2022 -$9.37 ▼
OE = CFO - change in working capital (WC) - SBC - maintenance capex. CFO=$(81,380)K. WC effect: AR $(8,504)K + inventory $(1,181)K + AP/accrued $(10,720)K = $(20,405)K (lease/deferred-revenue lines not separately tagged this year, assumed immaterial). SBC=$12,856K. Capex=$636K; revenue declined YoY (69,202->per FY22) so growth capex=$0, maintenance capex=capex=$636K. OE = -81,380-(-20,405)-12,856-636 = $(74,467)K. Diluted shares=7,950,757 (post 1-for-15 reverse split, as restated in the FY2023 10-K). OE/sh=$(9.37). Source: FY2023 10-K filed 2024-03-08, accession 0001628280-24-010048.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
Primarily United States, sold nationwide through major national retailers (Amazon, Walmart, Target, Best Buy) and direct-to-consumer; a growing minority of sales comes from international markets including Europe (Germany, and other EU/UK markets under CE/UKCA marking), Canada, Australia, New Zealand and South Africa, with an India launch planned.
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis
OWLT has traded as a classic small-cap, post-SPAC boom-bust-recovery chart: a sharp decline from the 2021 de-SPAC listing into 2022-2023 as cash-crisis and dilution fears dominated, a 1-for-15 reverse split in 2023 that reset the nominal share price, a choppy basing period through 2024, and a recovery attempt into 2025 helped by improving fundamentals and a further equity raise in October 2025 at $7.15 per share. Volatility remains high and the share count has grown substantially through repeated capital raises, both typical of a speculative small-cap turnaround story rather than a chart with an established, low-volatility trend. A chartist would flag the reverse split as a structural break that makes pre-2023 price history not directly comparable to the post-split chart, and would note that the stock's history is dominated by financing-driven moves (offering announcements, warrant/preferred developments) rather than a steady trend.
Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.